Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Hansoh BioMedical R&D Company.
Real, source-linked trial activity for Hansoh BioMedical R&D Company: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE2 1PHASE1 1
Newest Hansoh BioMedical R&D Company trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 3d ago | A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versu | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 31d ago | HS-20117-2 Injection in Patients With Advanced Solid Tumors | Ph 1 | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Hansoh BioMedical R&D Company (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.